Covid-19: European regulator approves 3rd dose of Pfizer vaccine for over 18s

Published on :

The injection of a third dose of Pfizer / BioNTech vaccine for those over 18 was validated on Monday by the European Medicines Agency (EMA), which leaves each member state of the European Union to decide on its own schedule. reminder.

The European regulator approved, Monday, October 4, the administration of a third dose of the Pfizer / BioNTech vaccine for those over 18, fearing that the protection against Covid-19 may decline after the first injections.

Additional doses of Moderna and Pfizer vaccines for people with severely weakened immune systems have also been approved by the European Medicines Agency (EMA), headquartered in Amsterdam.

“Booster doses of Comirnaty may be considered for people aged 18 and over, at least six months after the second dose,” EMA said in a statement, referring to the trade name of the Pfizer vaccine.

>> To see: Covid-19: in New Caledonia, increasingly young patients placed in intensive care

“Decisions on third doses will be made by public health bodies at the national level,” the EMA said.

The EMA’s Committee for Medicinal Products for Human Use (CHMP) has “evaluated data for Comirnaty showing an increase in antibody levels when a third dose is given”.

Third dose at least 28 days after the second for immunocompromised people

“The risk of inflammatory heart disease or other very rare side effects after a booster is not known and is carefully monitored,” the EMA added.

Rare cases of myocarditis, an inflammation of the heart muscle, have been reported in people who have received Pfizer vaccine, especially in young men.

Separately, the EMA has given the green light to people with “severely weakened immune systems” to get additional doses of Moderna and Pfizer at least 28 days after their second dose.

>> To see: Health pass: Europe at several speeds

Sometimes two doses are not enough to produce enough antibodies in people who are immunocompromised, such as people who have had an organ transplant.

“Although there is no direct evidence that the ability to produce antibodies in these patients protects against Covid-19, the additional dose is expected to increase protection at least in some patients,” said declared the EMA.

With AFP

1 thought on “Covid-19: European regulator approves 3rd dose of Pfizer vaccine for over 18s”

Comments are closed.